Aptamers Market Opportunity, Type and Application, Development Status, Segmentation and Forecast by 2022
According to Stratistics
MRC, the Global Aptamers market is expected to grow from $128.80 million in
2016 to reach $408.14 million by 2023 with a CAGR of 17.9%. Rising investments
in R&D of biotechnology and pharmaceutical industries, technological
advancements and high efficient and cost-reduced process for binding larger
molecules as compared to antibodies are the some of the key factors propelling
the market growth. However, lack of awareness about the technology in
developing economies and inadequate regulatory structure are hampering the
market. The increased applications of aptamers in the food and chemicals
industries are expected to create huge opportunities for market growth.
By product, the DNA
aptamers are expected to have huge potential in the diagnosis and treatment of
human disorder. DNA aptamers are generally used for the diagnosis of infectious
disorder, cancer and cardiovascular disorder. DNA aptamers are oligonucleotides
that bind to a variety of targets, such as small molecules, oligosaccharides,
peptides, proteins, and cells. They are generated by an evolutionary
engineering method called SELEX, using an oligonucleotide library with a
randomized sequence. Once DNA aptamer sequences are obtained by SELEX, the
aptamers can be chemically synthesized on a large GMP scale, for diagnostic and
therapeutic applications.
Geographically, North America holds the largest market shareduring the forecast period. Technological advancements, huge investments in R&D and developments in Aptamers are the major factors contributing to the growth of the market in this region.
Some of the key players in the Aptamers market are Aptamer Solutions Ltd, Somalogic, Inc., Vivonics, Inc, Aptus Biotech S.L, Base Pair Biotechnologies, Inc, Aptagen, LLC , Trilink Biotechnologies, Inc, Aptamer Sciences Inc, Neoventures Biotechnology Inc, Am Biotechnologies, LLC, NOXXON Pharma, Ophthotech Corporation , Novartis AG, NeoNeuro SAS and Apta Targets.
Geographically, North America holds the largest market shareduring the forecast period. Technological advancements, huge investments in R&D and developments in Aptamers are the major factors contributing to the growth of the market in this region.
Some of the key players in the Aptamers market are Aptamer Solutions Ltd, Somalogic, Inc., Vivonics, Inc, Aptus Biotech S.L, Base Pair Biotechnologies, Inc, Aptagen, LLC , Trilink Biotechnologies, Inc, Aptamer Sciences Inc, Neoventures Biotechnology Inc, Am Biotechnologies, LLC, NOXXON Pharma, Ophthotech Corporation , Novartis AG, NeoNeuro SAS and Apta Targets.
Full report with Table of
Content: https://marketreportscenter.com/reports/571494/aptamers-global-market-outlook-2017-2023
Applications Covered:
• Research and Development
• Forensics
• Cancer
• Diagnostics
• Therapeutics Development
• Biodefense
• Other Applications
End Users Covered:
• Contract Research Organizations
• Academic and Government Research Institutes
• Biotechnology and Pharmaceutical Companies
• Other End Users
Aptamers Types Covered:
• Peptide Aptamers
• Nucleic Acid Aptamers
• Research and Development
• Forensics
• Cancer
• Diagnostics
• Therapeutics Development
• Biodefense
• Other Applications
End Users Covered:
• Contract Research Organizations
• Academic and Government Research Institutes
• Biotechnology and Pharmaceutical Companies
• Other End Users
Aptamers Types Covered:
• Peptide Aptamers
• Nucleic Acid Aptamers
…
About
Market Reports Center;
Market Reports Center is an e-commerce platform
obliging the needs of knowledge workers, experts, professionals who are subject
to market research information for their work, or to make strategic business
decisions. We are dedicated to create a comprehensive offering of market
research which is accurate, credible and affordable.
Connect
for more details:
Sam
Collins
Market
Reports Center
1-646-883-3044
(US)
Comments
Post a Comment